Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | +2.45% | +16.67% | +14.29% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 87.85M | |
+9.06% | 105B | |
-0.58% | 104B | |
+5.79% | 22.94B | |
-12.57% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.82% | 16.96B | |
+8.20% | 14.16B | |
+39.22% | 12.63B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on Spero Therapeutics to $7 From $6, Keeps Buy Rating